Cite

HARVARD Citation

    Chai, S. et al. (2019). In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients. Human vaccines & immunotherapeutics. 15 (1), pp. 167-178. [Online]. 
  
Back to record